Patients with Recurrent Breast Cancer: Does the Primary Axillary Lymph node Status Predict more Aggressive Tumor Progression?

[1]  B. E. F. Isher,et al.  Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. , 2002 .

[2]  R. Gelber,et al.  Meeting highlights: international consensus panel on the treatment of primary breast cancer. , 2002, Journal of the National Cancer Institute.

[3]  J. Boyages,et al.  Treatment of the axilla in early breast cancer: past, present and future , 2001, ANZ journal of surgery.

[4]  D. Lampe,et al.  Prognostic Significance of Local Recurrence in Breast Cancer after Postmastectomy Radiotherapy , 2001, Strahlentherapie und Onkologie.

[5]  P. Sinha,et al.  Does radical surgery to the axilla give a survival advantage in more severe breast cancer? , 2001, European journal of cancer.

[6]  A. Paradiso,et al.  Failure of primary breast cancer neoangiogenesis to predict pattern of distant metastasis , 2001, Clinical and Experimental Medicine.

[7]  S. Braun,et al.  The fate and prognostic value of occult metastatic cells in the bone marrow of patients with breast carcinoma between primary treatment and recurrence , 2001, Cancer.

[8]  T. Brand,et al.  Understanding patterns of failure in breast cancer treatment argues for a more thorough investigation of axillary lymph nodes in node negative patients. , 2000, American journal of surgery.

[9]  Richard Sylvester,et al.  Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. , 2000, Journal of the National Cancer Institute.

[10]  D. Weaver,et al.  Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma , 2000, Cancer.

[11]  Miller.  NCI monograph links secondhand smoke to cancer and other diseases , 2000, Journal of the National Cancer Institute.

[12]  S G Hilsenbeck,et al.  Significance of axillary lymph node metastasis in primary breast cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  Ana Lluch,et al.  Prognostic factors predicting survival from first recurrence in patients with metastatic breast cancer: analysis of 439 patients , 1999, Breast Cancer Research and Treatment.

[14]  S. Edge,et al.  Treatment of early-stage breast cancer. , 1999, Current problems in cancer.

[15]  N. Col,et al.  The learning curve for sentinel node biopsy in breast cancer: practical considerations. , 1999, Archives of surgery.

[16]  J. Donohue,et al.  Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer? , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  R. Gray,et al.  Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  J. Foekens,et al.  Breast-conserving therapy: proteases as risk factors in relation to survival after local relapse. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  D. Carter.  TNM Classification of Malignant Tumors , 1998 .

[20]  Mike Clarke,et al.  Polychemotherapy for early breast cancer: an overview of the randomised trials , 1998, The Lancet.

[21]  J. Gurwitz,et al.  The quality of care for treatment of early stage breast carcinoma , 1998, Cancer.

[22]  M. Narabayashi,et al.  Construction and validation of a practical prognostic index for patients with metastatic breast cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  Mike Clarke,et al.  Tamoxifen for early breast cancer: an overview of the randomised trials , 1998, The Lancet.

[24]  P. Sperduto,et al.  Prognostic factors after conservative surgery and radiation therapy for early stage breast cancer. , 1998, American journal of clinical oncology.

[25]  L. Sobin,et al.  TNM classification of malignant tumors, fifth edition (1997) , 1997, Cancer.

[26]  L. Sengeløv,et al.  Pattern of dissemination and survival following isolated locoregional recurrence of breast cancer , 1997, Breast Cancer Research and Treatment.

[27]  S. Cavanaugh,et al.  The Role of Axillary Node Dissection in Mammographically Detected Carcinoma , 1997 .

[28]  D. Dent,et al.  Mastectomy with axillary clearance versus mastectomy without it. Late results of a trial in which patients had no adjuvant chemo-, radio- or endocrine therapy. , 1996, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[29]  M. Dhodapkar,et al.  Prognostic factors in elderly women with metastatic breast cancer treated with tamoxifen: An analysis of patients entered on four prospective clinical trials , 1996, Cancer.

[30]  R. Steele,et al.  The Edinburgh randomized trial of axillary sampling or clearance after mastectomy , 1995, The British journal of surgery.

[31]  A. Luini,et al.  Breast conservation is a safe method in patients with small cancer of the breast. Long-term results of three randomised trials on 1,973 patients. , 1995, European journal of cancer.

[32]  M. P. Moore,et al.  The surgical management of primary invasive breast cancer , 1995, CA: a cancer journal for clinicians.

[33]  P Okunieff,et al.  Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. , 1995, The New England journal of medicine.

[34]  E. Zubizarreta,et al.  Breast conservation treatment of early stage breast cancer: patterns of failure. , 1995, International journal of radiation oncology, biology, physics.

[35]  D. Schaid,et al.  Patterns of tumor relapse following mastectomy and adjuvant systemic therapy in patients with axillary lymph node‐positive breast cancer. Impact of clinical, histopathologic, and flow cytometric factors , 1993, Cancer.

[36]  D. Fischer,et al.  Prognostic value of DNA flow cytometry in the locally recurrent, conservatively treated breast cancer patient , 1992 .

[37]  I. Mittra,et al.  A meta-analysis of reported correlations between prognostic factors in breast cancer: does axillary lymph node metastasis represent biology or chronology? , 1991, European journal of cancer.

[38]  Stephen E. Jones.  Implications of the NIH Consensus Development Conference on the Treatment of Early-Stage Breast Cancer , 1991 .

[39]  H. Inakoshi,et al.  Radiation Therapy of Breast Cancer(The Evolution of Carcinoma of the Mamma) , 1990 .

[40]  S Friedman,et al.  Prognostic value of histologic grade nuclear components of Scarff‐Bloom‐Richardson (SBR). An improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas , 1989, Cancer.

[41]  B Fisher,et al.  Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. , 1989, The New England journal of medicine.

[42]  R. Arriagada,et al.  Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. , 1989, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[43]  H. Senn,et al.  [Loco-regional recurrence following surgery of breast carcinoma: prognostic factors and therapeutic consequences]. , 1988, Schweizerische medizinische Wochenschrift.

[44]  C. Mueller.  Stage II breast cancer is not simply a late stage I. , 1988, Surgery.

[45]  W. Godolphin,et al.  Model for breast cancer survival: relative prognostic roles of axillary nodal status, TNM stage, estrogen receptor concentration, and tumor necrosis. , 1988, Cancer research.

[46]  C Kamby,et al.  Stage and pattern of metastases in patients with breast cancer. , 1987, European journal of cancer & clinical oncology.

[47]  M. Williams,et al.  Survival patterns in hormone treated advanced breast cancer , 1986, The British journal of surgery.

[48]  A. Ardizzoni,et al.  Survival of patients with relapsing breast cancer: analysis of 302 patients. , 1986, Oncology.

[49]  B Fisher,et al.  Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. , 1985, The New England journal of medicine.

[50]  D. Barnes,et al.  The effect of oestrogen and progesterone receptors on recurrence and survival in patients with carcinoma of the breast. , 1985, British Journal of Cancer.

[51]  A. Howell,et al.  STEROID-HORMONE RECEPTORS AND SURVIVAL AFTER FIRST RELAPSE IN BREAST CANCER , 1984, The Lancet.

[52]  N. Natarajan,et al.  Breast cancer in the medial half. Results of 1978 national survey of the American College of surgeons , 1983, Cancer.

[53]  A. Lees,et al.  Influence and significance of certain prognostic factors on survival in breast cancer. , 1982, European journal of cancer & clinical oncology.

[54]  R. Hähnel,et al.  Prognostic value of estrogen receptors in primary breast cancer , 1979, Cancer.

[55]  I. Onuma.  [Radiation therapy of breast cancer]. , 1967, Iryo.

[56]  Braimbridge Mv.  HAEMOLYTIC ANAEMIA AND ACUTE RENAL DISEASE. , 1965 .

[57]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[58]  H. Bloom,et al.  Histological Grading and Prognosis in Breast Cancer , 1957, British Journal of Cancer.

[59]  W. Halsted.  I. A Clinical and Histological Study of certain Adenocarcinomata of the Breast: and a Brief Consideration of the Supraclavicular Operation and of the Results of Operations for Cancer of the Breast from 1889 to 1898 at the Johns Hopkins Hospital. , 1898, Annals of surgery.

[60]  V. Kosma,et al.  Mitotic indexes as prognostic predictors in female breast cancer , 2005, Journal of Cancer Research and Clinical Oncology.

[61]  L. Beex,et al.  Human breast cancer: survival from first metastasis , 2005, Breast Cancer Research and Treatment.

[62]  S. Hollenbeck,et al.  Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer. , 2002, American journal of surgery.

[63]  Jong-Hyeon Jeong,et al.  Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. , 2002, The New England journal of medicine.

[64]  E. Touboul,et al.  Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer. , 1999, International journal of radiation oncology, biology, physics.

[65]  S. Cavanaugh,et al.  The role of axillary dissection in mammographically detected carcinoma. , 1997, Journal of the American College of Surgeons.

[66]  R. Gelber,et al.  IX. International consensus conference on primary treatment of breast cancer. , 1996, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[67]  F. Spyratos,et al.  Prognostic factor clustering in breast cancer: biology or chronology? , 1995, European journal of cancer.

[68]  J. Willner,et al.  [Does primary tumor affect the prognosis in postmastectomy locoregional recurrence in breast carcinoma?]. , 1995, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

[69]  S. Schnitt,et al.  Prognosis following salvage mastectomy for recurrence in the breast after conservative surgery and radiation therapy for early-stage breast cancer. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[70]  L. Beex,et al.  Human breast cancer: survival from first metastasis. Breast Cancer Study Group. , 1992, Breast cancer research and treatment.

[71]  L. Skoog,et al.  Prognostic significance of axillary nodal status in primary breast cancer in relation to the number of resected nodes. Stockholm Breast Cancer Study Group. , 1992, Acta oncologica.

[72]  H. Mouridsen,et al.  Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group. , 1992, Journal of the National Cancer Institute. Monographs.

[73]  H. Böttcher.  [Radiation therapy in breast carcinoma]. , 1991, Zentralblatt fur Gynakologie.

[74]  C. Bressac,et al.  The prognostic significance of late local recurrence after breast-conserving therapy. , 1990, International journal of radiation oncology, biology, physics.

[75]  D. Schultz,et al.  Breast recurrence following conservative surgery and radiation: patterns of failure, prognosis, and pathologic findings from mastectomy specimens with implications for treatment. , 1990, International journal of radiation oncology, biology, physics.

[76]  G M Clark,et al.  Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[77]  D.,et al.  Regression Models and Life-Tables , 2022 .